Taken together, the present study identified GPRC5A as a protective factor against the progression of human triple-negative breast cancer by increasing cell apoptosis via the regulation of the PI3K/Akt signaling pathway. The gene discussed is AKT1; the disease is triple-negative breast carcinoma.